Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.

Bonneau KR, Ng S, Foster H, Choi KB, Berkhout B, Rabson A, Mackewicz CE, Levy JA.

Virology. 2008 Mar 30;373(1):30-8. Epub 2007 Dec 20.

2.

Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.

McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.

Virology. 2000 Sep 1;274(2):262-77.

4.

CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.

Barker E.

J Infect Dis. 1999 May;179 Suppl 3:S485-8. Review.

PMID:
10099125
5.

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.

Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B.

J Virol. 2000 Apr;74(8):3740-51.

6.

CD8+ cell noncytotoxic antiviral response in long-term HIV-1 infected former blood donors in China.

Yuan L, Ma L, Fan X, Feng Y, Peng H, Zhao Q, Ruan Y, Levy JA, Shao Y.

Curr HIV Res. 2009 Jul;7(4):437-40.

PMID:
19601780
7.

Transcriptional regulation of HIV-1 LTR during antigen-dependent activation of primary T cells by dendritic cells.

Tsunetsugu-Yokota Y, Kato T, Yasuda S, Matsuda Z, Suzuki Y, Koyanagi Y, Yamamoto N, Akagawa K, Cho MW, Takemori T.

J Leukoc Biol. 2000 Mar;67(3):432-40.

PMID:
10733105
8.
10.

alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors.

Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, Selsted ME, Levy JA.

AIDS. 2003 Sep 26;17(14):F23-32. Erratum in: AIDS. 2003 Sep 26;17(14):F31.

PMID:
14502030
11.

CD8+ cell anti-HIV activity rapidly increases upon discontinuation of early antiretroviral therapy.

Killian MS, Roop J, Ng S, Hecht FM, Levy JA.

J Clin Immunol. 2009 May;29(3):311-8. doi: 10.1007/s10875-009-9275-y. Epub 2009 Feb 3.

PMID:
19189205
12.

Cellular specificity of HIV-1 replication can be controlled by LTR sequences.

Reed-Inderbitzin E, Maury W.

Virology. 2003 Sep 30;314(2):680-95.

13.

Increased number of single-LTR HIV-1 DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo.

Jurriaans S, de Ronde A, Dekker J, Cornelissen M, Goudsmit J.

J Med Virol. 1995 Jan;45(1):91-8.

PMID:
7714497
14.
15.

[CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].

Yuan L, Ma LY, Zang XH, Meng XD, Peng H, Zhao QB, Xing H, Shao YM.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Jun;22(3):195-7. Chinese.

PMID:
19031701
17.

O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.

Jochmann R, Thurau M, Jung S, Hofmann C, Naschberger E, Kremmer E, Harrer T, Miller M, Schaft N, St├╝rzl M.

J Virol. 2009 Apr;83(8):3704-18. doi: 10.1128/JVI.01384-08. Epub 2009 Feb 4.

18.
19.

CD8+ T-cell-mediated non-cytolytic suppression of human immuno-deficiency viruses.

Vella C, Daniels RS.

Curr Drug Targets Infect Disord. 2003 Jun;3(2):97-113. Review.

PMID:
12769788
20.

A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

Emiliani S, Van Lint C, Fischle W, Paras P Jr, Ott M, Brady J, Verdin E.

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6377-81.

Supplemental Content

Support Center